Lipid Luminations

Lipid Luminations

By ReachMDMedicine
Download on the App Store

Lipid Luminations episodes

  • Looking Beyond LDL to Reduce Cardiovascular Events
    Host: Larry Kaskel, MD
    Guest: Alan S. Brown, MD, FACC, FAHA, FNLA

    To effectively reduce one's cardiovascular risk, recent studies suggest it is necessary to treat multiple factors and not just the patient's LDL number. Dr. Brown discusses with host Dr. Larry Kaskel how studies that used a multi-factor approach, such as the Steno studies and the Champ study, dramatically reduced the incidents of cardiovascular events. Advance lipid testing according to Dr. Brown should only be used for borderline patients, and is not necessary for patients where the risk is apparent from the general blood/lipid panel numbers. Dr. Brown also highlights the need for a prospective clinical trial, which focuses on non-HDL numbers and particles.

    Brought to you by:

    13 min
  • Metabolic Syndrome in Children and Adolescents
    Host: Larry Kaskel, MD
    Guest: Catherine McNeal, MD

    Dr. Larry Kaskel welcomes Dr. Catherine McNeal to Lipid Luminations. Dr. McNeal is an Associate Professor of Pediatrics and Associate Professor of Internal Medicine at The Texas A&M Health Science Center, College Station, Texas. Dr. McNeal will discuss the features of metabolic syndrome in children and adolescents and why early intervention is so important. She will also talk about the problem in diagnosing the metabolic syndrome in youth based on the dynamic changes in the parameters associated with growth and maturation.

    Brought to you by:

    13 min
  • Managing Insulin-Resistant Patients With Multiple Risk Factors
    Host: Larry Kaskel, MD
    Guest: Yehuda Handelsman, MD

    Host Dr. Larry Kaskel welcomes Dr. Yehuda Handelsman, medical director of the Metabolic Institute of America and chair of the International Committee for Insulin Resistance. Dr. Handelsman examines the relationship of insulin resistance to metabolic syndrome, as well as a series of clinical conditions associated with insulin resistance. He also highlights lifestyle modifications and other treatment measures for patients with multiple risk factors.

    Brought to you by:

    13 min
  • The Latest Targets of Lipid Therapy
    Host: Larry Kaskel, MD
    Guest: Alan S. Brown, MD, FACC, FAHA, FNLA

    Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and other common risk factors? In these cases, when are statin therapies not enough to provide optimal care? Dr. Brown also opines on the value of residual risk measurements.

    Brought to you by:

    13 min
  • Does ApoB Trump Non-HDL Measurements?
    Host: Larry Kaskel, MD
    Guest: Allan Sniderman, MD

    Consensus is building around apolipoprotein B (apoB) as the preferred tool for gauging the effectiveness of LDL-lowering therapies. Is it accurate, reproducible and cost-effective? Host Dr. Larry Kaskel welcomes Dr. Allan Sniderman, professor of cardiology at the McGill University Health Centre in Montreal, for a noteworthy discussion about apoB and its impact on our approach to atherogenic risk management. Will this test soon become standard in a lipid panel?

    Brought to you by:

    13 min
  • Polycystic Ovary Disease
    Host: Larry Kaskel, MD
    Guest: Tara Dall

    Host Dr. Larry Kaskel welcomes Dr. Tara Dall, board-certified lipidologist at Advanced Lipidology in Wisconsin, to discuss chronic anovulation and hyperandrogenism, and its association with an increased risk of diabetes, metabolic syndrome and cardiac problems. She will also highight treatment options.

    Brought to you by:

    13 min
  • LDL Apheresis
    Host: Larry Kaskel, MD
    Guest: Donna Polk, MD

    Dr. Larry Kaskel welcomes Dr. Donna Polk to Lipid Luminations. Dr. Polk is Director of Preventive Cardiology at Hartford Hospital in Hartford, Conneticut. Dr. Polk will discuss LDL Apheresis and the evidence supporting its use, what the procedure entails as well as who is eligible and where it is performed.

    Brought to you by:

    13 min
  • Advanced Cholesterol Testing
    Host: Larry Kaskel, MD
    Guest: Michael Richman, MD

    Heart disease is the number one killer of both men and women in the United States notwithstanding the performance of over 125 million lipid panel. Guest Dr. Michael Richman discusses with host Dr. Larry Kaskel various advance cholesterol testing mechanism that could provide the necessary information to reduce the risk of a cardiovascular event. Dr. Richman also explains why advanced cholesterol testing is not performed more routinely and often omitted for even those patients presenting the greatest risk factors.

    Brought to you by:

    13 min
  • CVD Risk in Special Female Populations
    Host: Larry Kaskel, MD
    Guest: Robert Wild, MD, MPH, D.Phil.

    Many studies suggest that metabolic syndrome is a more accurate predictor of cardiovascular disease in women, many of whom are vulnerable to the disease process starting in their late teenage years and extending post-menopause. Is there an ideal age at which to begin focusing our attention here? Host Dr. Larry Kaskel welcomes Robert Wild, MD, PhD, MPH, professor of reproductive endocrinology at the University of Oklahoma College of Medicine, to tackle questions on atherosclerotic cardiovascular disease and its link to metabolic syndrome.

    Brought to you by:

    13 min
  • The COURAGE Trial: Unpopular to Some, Embraced by Many
    Host: Larry Kaskel, MD
    Guest: William Boden, MD, FACC, FAHA

    Dr. Larry Kaskel welcomes Dr. William Boden to Lipid Luminations. Dr. Boden is the medical director of cardiovascular services at Kaleida Health and chief of cardiology at Buffalo General and Millard Fillmore Hospitals. Dr. Boden is extremely well-versed on the COURAGE Trial and will explore where COURAGE provides clarity of management and where its results leave us with uncertainty.

    Brought to you by:

    13 min

About Lipid Luminations

From the publisher's feed

Get to the heart of the most recent advances in lipid management and cardiovascular disease with Lipid Luminations, which features scientific and clinical research updates, novel…